ReviewPediatric gastroenterology, hepatology & nutrition2026
Microbial Profile Alteration as a Potential Biomarker and Therapeutic Target in Children with Celiac Disease: A Narrative Review.
Review in Pediatric gastroenterology, hepatology & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion in genetically susceptible individuals. While gluten exposure is a necessary environmental trigger, its interaction with the intestinal microbiota has recently been recognized as a critical factor in modulating the onset and progression of the disease. Emerging evidence suggests that compositional and functional alterations in the microbial community may contribute to CD's pathogenesis by influencing intestinal barrier integrity, antigen presentation, and the balance between pro- and anti-inflammatory immune responses. Consequently, detailed characterization of microbial signatures holds promise for the identification of biomarkers for early diagnosis and development of microbiota-targeted interventions. This narrative review comprehensively analyzed observational human studies and controlled clinical trials to assess the role of microbiota in pediatric CD. Moreover, dysbiosis patterns across gastrointestinal niches in children with CD were compared and discussed. These findings have the potential for use in novel diagnostic and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.